Price $87.88 |
Market Cap
3.29B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
85.2
|
P/B
4.43
|
P/S
4.01
|
Dividend %
-
|
|
P/CF
98.9
|
P/FCF
35.6
|
Op. Cash Flow
111.6K
|
FCF
2.2
|
|
Op. Margin
7.00%
|
Net Margin
4.70%
|
ROE
5.90%
|
ROI
5.70%
|
|
ROA
3.50%
|
EPS Growth
-15.70%
|
Current Ratio
1.9
|
Debt/Equity
19.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cocrystal Pharma Inc (COCP) | $2.09 | - | - | 74.4M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.04 | - | - | 87.4M | Strong Buy |
| Hologic, Inc. (HOLX) | $48.52 | - | - | 11.78B | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.60 | - | - | 44.5M | Strong Buy |
| Lannett Company, Inc. (LCI) | $5.64 | - | - | 215.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
